Concepedia

Tracy Kemp

TK

Statistics

Publications

4

Citations

327

H-Index

4

Active since

2005

Affiliations

NewLink Genetics (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Tracy Kemp is an author at NewLink Genetics (United States) specializing in vaccine development, medicine, and vaccination.

Top concepts

Publications per year

2005–2017

4

Publications

4

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

D. Gray Heppner, Tracy Kemp, Brian K. Martin et al. · The Lancet Infectious Diseases · 2017 · 118 citations · Full text

, , +9

A novel, cell culture-derived smallpox vaccine in vaccinia-naïve adults

Andrew W. Artenstein, Casey Johnson, Thomas Marbury et al. · Vaccine · 2005 · 83 citations

, , +5

Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial

May ElSherif, Catherine Brown, Donna MacKinnon‐Cameron et al. · Canadian Medical Association Journal · 2017 · 77 citations · Full text

Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic

Beth-Ann Coller, Jeffrey T. Blue, Rituparna Das et al. · Vaccine · 2017 · 49 citations

, , +9

1–4 of 4